Global Leber Congenital Amaurosis (LCA) Market Growth (Status and Outlook) 2025-2031

September 2025 | 73 pages | ID: G9AD7B23D889EN
LP Information

Abstracts

According to this study, the global Leber Congenital Amaurosis (LCA) market size will reach US$ million by 2031.

Leber congenital amaurosis is a kind of autosomal recessive genetic disease, it is the main genetic disease that brings about children blindness, accompany mental nerve symptom, wait like intellectual inferior, hearing obstacle, epilepsy, conus cornea can happen when some age is older or spherical cornea.

United States market for Leber Congenital Amaurosis (LCA) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Leber Congenital Amaurosis (LCA) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Leber Congenital Amaurosis (LCA) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Leber Congenital Amaurosis (LCA) players cover AmpliPhi Biosciences, Editas Medicine, Novelion Therapeutics, ProQR Therapeutics, Spark Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Leber Congenital Amaurosis (LCA) Industry Forecast” looks at past sales and reviews total world Leber Congenital Amaurosis (LCA) sales in 2024, providing a comprehensive analysis by region and market sector of projected Leber Congenital Amaurosis (LCA) sales for 2025 through 2031. With Leber Congenital Amaurosis (LCA) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Leber Congenital Amaurosis (LCA) industry.

This Insight Report provides a comprehensive analysis of the global Leber Congenital Amaurosis (LCA) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Leber Congenital Amaurosis (LCA) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Leber Congenital Amaurosis (LCA) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Leber Congenital Amaurosis (LCA) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Leber Congenital Amaurosis (LCA).

This report presents a comprehensive overview, market shares, and growth opportunities of Leber Congenital Amaurosis (LCA) market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Infantile Type
• Juvenile Type

Segmentation by Application:

• Hospitals
• Eye Clinics
• Medical Research Institute
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AmpliPhi Biosciences
• Editas Medicine
• Novelion Therapeutics
• ProQR Therapeutics
• Spark Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Leber Congenital Amaurosis (LCA) Market Size (2020-2031)
  2.1.2 Leber Congenital Amaurosis (LCA) Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Leber Congenital Amaurosis (LCA) by Country/Region (2020, 2024 & 2031)
2.2 Leber Congenital Amaurosis (LCA) Segment by Type
  2.2.1 Infantile Type
  2.2.2 Juvenile Type
2.3 Leber Congenital Amaurosis (LCA) Market Size by Type
  2.3.1 Leber Congenital Amaurosis (LCA) Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2020-2025)
2.4 Leber Congenital Amaurosis (LCA) Segment by Application
  2.4.1 Hospitals
  2.4.2 Eye Clinics
  2.4.3 Medical Research Institute
  2.4.4 Other
2.5 Leber Congenital Amaurosis (LCA) Market Size by Application
  2.5.1 Leber Congenital Amaurosis (LCA) Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2020-2025)

3 LEBER CONGENITAL AMAUROSIS (LCA) MARKET SIZE BY PLAYER

3.1 Leber Congenital Amaurosis (LCA) Market Size Market Share by Player
  3.1.1 Global Leber Congenital Amaurosis (LCA) Revenue by Player (2020-2025)
  3.1.2 Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Player (2020-2025)
3.2 Global Leber Congenital Amaurosis (LCA) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LEBER CONGENITAL AMAUROSIS (LCA) BY REGION

4.1 Leber Congenital Amaurosis (LCA) Market Size by Region (2020-2025)
4.2 Global Leber Congenital Amaurosis (LCA) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Leber Congenital Amaurosis (LCA) Market Size Growth (2020-2025)
4.4 APAC Leber Congenital Amaurosis (LCA) Market Size Growth (2020-2025)
4.5 Europe Leber Congenital Amaurosis (LCA) Market Size Growth (2020-2025)
4.6 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Leber Congenital Amaurosis (LCA) Market Size by Country (2020-2025)
5.2 Americas Leber Congenital Amaurosis (LCA) Market Size by Type (2020-2025)
5.3 Americas Leber Congenital Amaurosis (LCA) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Leber Congenital Amaurosis (LCA) Market Size by Region (2020-2025)
6.2 APAC Leber Congenital Amaurosis (LCA) Market Size by Type (2020-2025)
6.3 APAC Leber Congenital Amaurosis (LCA) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Leber Congenital Amaurosis (LCA) Market Size by Country (2020-2025)
7.2 Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2020-2025)
7.3 Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Leber Congenital Amaurosis (LCA) by Region (2020-2025)
8.2 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Type (2020-2025)
8.3 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LEBER CONGENITAL AMAUROSIS (LCA) MARKET FORECAST

10.1 Global Leber Congenital Amaurosis (LCA) Forecast by Region (2026-2031)
  10.1.1 Global Leber Congenital Amaurosis (LCA) Forecast by Region (2026-2031)
  10.1.2 Americas Leber Congenital Amaurosis (LCA) Forecast
  10.1.3 APAC Leber Congenital Amaurosis (LCA) Forecast
  10.1.4 Europe Leber Congenital Amaurosis (LCA) Forecast
  10.1.5 Middle East & Africa Leber Congenital Amaurosis (LCA) Forecast
10.2 Americas Leber Congenital Amaurosis (LCA) Forecast by Country (2026-2031)
  10.2.1 United States Market Leber Congenital Amaurosis (LCA) Forecast
  10.2.2 Canada Market Leber Congenital Amaurosis (LCA) Forecast
  10.2.3 Mexico Market Leber Congenital Amaurosis (LCA) Forecast
  10.2.4 Brazil Market Leber Congenital Amaurosis (LCA) Forecast
10.3 APAC Leber Congenital Amaurosis (LCA) Forecast by Region (2026-2031)
  10.3.1 China Leber Congenital Amaurosis (LCA) Market Forecast
  10.3.2 Japan Market Leber Congenital Amaurosis (LCA) Forecast
  10.3.3 Korea Market Leber Congenital Amaurosis (LCA) Forecast
  10.3.4 Southeast Asia Market Leber Congenital Amaurosis (LCA) Forecast
  10.3.5 India Market Leber Congenital Amaurosis (LCA) Forecast
  10.3.6 Australia Market Leber Congenital Amaurosis (LCA) Forecast
10.4 Europe Leber Congenital Amaurosis (LCA) Forecast by Country (2026-2031)
  10.4.1 Germany Market Leber Congenital Amaurosis (LCA) Forecast
  10.4.2 France Market Leber Congenital Amaurosis (LCA) Forecast
  10.4.3 UK Market Leber Congenital Amaurosis (LCA) Forecast
  10.4.4 Italy Market Leber Congenital Amaurosis (LCA) Forecast
  10.4.5 Russia Market Leber Congenital Amaurosis (LCA) Forecast
10.5 Middle East & Africa Leber Congenital Amaurosis (LCA) Forecast by Region (2026-2031)
  10.5.1 Egypt Market Leber Congenital Amaurosis (LCA) Forecast
  10.5.2 South Africa Market Leber Congenital Amaurosis (LCA) Forecast
  10.5.3 Israel Market Leber Congenital Amaurosis (LCA) Forecast
  10.5.4 Turkey Market Leber Congenital Amaurosis (LCA) Forecast
10.6 Global Leber Congenital Amaurosis (LCA) Forecast by Type (2026-2031)
10.7 Global Leber Congenital Amaurosis (LCA) Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Leber Congenital Amaurosis (LCA) Forecast

11 KEY PLAYERS ANALYSIS

11.1 AmpliPhi Biosciences
  11.1.1 AmpliPhi Biosciences Company Information
  11.1.2 AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Product Offered
  11.1.3 AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AmpliPhi Biosciences Main Business Overview
  11.1.5 AmpliPhi Biosciences Latest Developments
11.2 Editas Medicine
  11.2.1 Editas Medicine Company Information
  11.2.2 Editas Medicine Leber Congenital Amaurosis (LCA) Product Offered
  11.2.3 Editas Medicine Leber Congenital Amaurosis (LCA) Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Editas Medicine Main Business Overview
  11.2.5 Editas Medicine Latest Developments
11.3 Novelion Therapeutics
  11.3.1 Novelion Therapeutics Company Information
  11.3.2 Novelion Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
  11.3.3 Novelion Therapeutics Leber Congenital Amaurosis (LCA) Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Novelion Therapeutics Main Business Overview
  11.3.5 Novelion Therapeutics Latest Developments
11.4 ProQR Therapeutics
  11.4.1 ProQR Therapeutics Company Information
  11.4.2 ProQR Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
  11.4.3 ProQR Therapeutics Leber Congenital Amaurosis (LCA) Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 ProQR Therapeutics Main Business Overview
  11.4.5 ProQR Therapeutics Latest Developments
11.5 Spark Therapeutics
  11.5.1 Spark Therapeutics Company Information
  11.5.2 Spark Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
  11.5.3 Spark Therapeutics Leber Congenital Amaurosis (LCA) Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Spark Therapeutics Main Business Overview
  11.5.5 Spark Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Leber Congenital Amaurosis (LCA) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Leber Congenital Amaurosis (LCA) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Infantile Type
Table 4. Major Players of Juvenile Type
Table 5. Leber Congenital Amaurosis (LCA) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Leber Congenital Amaurosis (LCA) Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2020-2025)
Table 8. Leber Congenital Amaurosis (LCA) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Leber Congenital Amaurosis (LCA) Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2020-2025)
Table 11. Global Leber Congenital Amaurosis (LCA) Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Player (2020-2025)
Table 13. Leber Congenital Amaurosis (LCA) Key Players Head office and Products Offered
Table 14. Leber Congenital Amaurosis (LCA) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Leber Congenital Amaurosis (LCA) Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Region (2020-2025)
Table 19. Global Leber Congenital Amaurosis (LCA) Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Leber Congenital Amaurosis (LCA) Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Leber Congenital Amaurosis (LCA) Market Size Market Share by Country (2020-2025)
Table 23. Americas Leber Congenital Amaurosis (LCA) Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2020-2025)
Table 25. Americas Leber Congenital Amaurosis (LCA) Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2020-2025)
Table 27. APAC Leber Congenital Amaurosis (LCA) Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Leber Congenital Amaurosis (LCA) Market Size Market Share by Region (2020-2025)
Table 29. APAC Leber Congenital Amaurosis (LCA) Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Leber Congenital Amaurosis (LCA) Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Leber Congenital Amaurosis (LCA) Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Leber Congenital Amaurosis (LCA) Market Size Market Share by Country (2020-2025)
Table 33. Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Leber Congenital Amaurosis (LCA)
Table 39. Key Market Challenges & Risks of Leber Congenital Amaurosis (LCA)
Table 40. Key Industry Trends of Leber Congenital Amaurosis (LCA)
Table 41. Global Leber Congenital Amaurosis (LCA) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Leber Congenital Amaurosis (LCA) Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Leber Congenital Amaurosis (LCA) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Leber Congenital Amaurosis (LCA) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. AmpliPhi Biosciences Details, Company Type, Leber Congenital Amaurosis (LCA) Area Served and Its Competitors
Table 46. AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Product Offered
Table 47. AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AmpliPhi Biosciences Main Business
Table 49. AmpliPhi Biosciences Latest Developments
Table 50. Editas Medicine Details, Company Type, Leber Congenital Amaurosis (LCA) Area Served and Its Competitors
Table 51. Editas Medicine Leber Congenital Amaurosis (LCA) Product Offered
Table 52. Editas Medicine Leber Congenital Amaurosis (LCA) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Editas Medicine Main Business
Table 54. Editas Medicine Latest Developments
Table 55. Novelion Therapeutics Details, Company Type, Leber Congenital Amaurosis (LCA) Area Served and Its Competitors
Table 56. Novelion Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
Table 57. Novelion Therapeutics Leber Congenital Amaurosis (LCA) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Novelion Therapeutics Main Business
Table 59. Novelion Therapeutics Latest Developments
Table 60. ProQR Therapeutics Details, Company Type, Leber Congenital Amaurosis (LCA) Area Served and Its Competitors
Table 61. ProQR Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
Table 62. ProQR Therapeutics Leber Congenital Amaurosis (LCA) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. ProQR Therapeutics Main Business
Table 64. ProQR Therapeutics Latest Developments
Table 65. Spark Therapeutics Details, Company Type, Leber Congenital Amaurosis (LCA) Area Served and Its Competitors
Table 66. Spark Therapeutics Leber Congenital Amaurosis (LCA) Product Offered
Table 67. Spark Therapeutics Leber Congenital Amaurosis (LCA) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Spark Therapeutics Main Business
Table 69. Spark Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Leber Congenital Amaurosis (LCA) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Leber Congenital Amaurosis (LCA) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Leber Congenital Amaurosis (LCA) Sales Market Share by Country/Region (2024)
Figure 8. Leber Congenital Amaurosis (LCA) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Type in 2024
Figure 10. Leber Congenital Amaurosis (LCA) in Hospitals
Figure 11. Global Leber Congenital Amaurosis (LCA) Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Leber Congenital Amaurosis (LCA) in Eye Clinics
Figure 13. Global Leber Congenital Amaurosis (LCA) Market: Eye Clinics (2020-2025) & ($ millions)
Figure 14. Leber Congenital Amaurosis (LCA) in Medical Research Institute
Figure 15. Global Leber Congenital Amaurosis (LCA) Market: Medical Research Institute (2020-2025) & ($ millions)
Figure 16. Leber Congenital Amaurosis (LCA) in Other
Figure 17. Global Leber Congenital Amaurosis (LCA) Market: Other (2020-2025) & ($ millions)
Figure 18. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Application in 2024
Figure 19. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Player in 2024
Figure 20. Global Leber Congenital Amaurosis (LCA) Market Size Market Share by Region (2020-2025)
Figure 21. Americas Leber Congenital Amaurosis (LCA) Market Size 2020-2025 ($ millions)
Figure 22. APAC Leber Congenital Amaurosis (LCA) Market Size 2020-2025 ($ millions)
Figure 23. Europe Leber Congenital Amaurosis (LCA) Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size 2020-2025 ($ millions)
Figure 25. Americas Leber Congenital Amaurosis (LCA) Value Market Share by Country in 2024
Figure 26. United States Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Leber Congenital Amaurosis (LCA) Market Size Market Share by Region in 2024
Figure 31. APAC Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2020-2025)
Figure 32. APAC Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2020-2025)
Figure 33. China Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 37. India Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Leber Congenital Amaurosis (LCA) Market Size Market Share by Country in 2024
Figure 40. Europe Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2020-2025)
Figure 41. Europe Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2020-2025)
Figure 42. Germany Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 43. France Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Leber Congenital Amaurosis (LCA) Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 56. APAC Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 57. Europe Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 59. United States Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 60. Canada Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 61. Mexico Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 62. Brazil Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 63. China Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 64. Japan Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 65. Korea Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 67. India Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 68. Australia Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 69. Germany Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 70. France Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 71. UK Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 72. Italy Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 73. Russia Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 74. Egypt Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 75. South Africa Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 76. Israel Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 77. Turkey Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)
Figure 78. Global Leber Congenital Amaurosis (LCA) Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Leber Congenital Amaurosis (LCA) Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Leber Congenital Amaurosis (LCA) Market Size 2026-2031 ($ millions)